About Dicle Uni Medical Faculty; Internal Medicine
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Clinical Trials at Dicle Uni Medical Faculty; Internal Medicine
During the past decade, Dicle Uni Medical Faculty; Internal Medicine conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
2008-05-14
2010-06-22
Completed
132
A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)
2017-08-25
2023-01-17
Completed
653
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer
2018-01-06
2023-01-04
Completed
580
A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus
2021-06-25
2025-06-30
Recruiting
210
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Dicle Uni Medical Faculty; Internal Medicine
According to Clinical.Site data, the most researched conditions in "Dicle Uni Medical Faculty; Internal Medicine" are
"Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials), "Anemia" (1 trials), "Breast Cancer" (1 trials) and "Triple-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Dicle Uni Medical Faculty; Internal Medicine" in a lesser frequency.
Clinical Trials Intervention Types at Dicle Uni Medical Faculty; Internal Medicine
Most popular intervention types in "Dicle Uni Medical Faculty; Internal Medicine" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials), "Atezolizumab Placebo" (1 trials), "Ipatasertib" (1 trials) and "Lomvastomig" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Dicle Uni Medical Faculty; Internal Medicine
The vast majority of trials in "Dicle Uni Medical Faculty; Internal Medicine" are
4 trials for "All" genders.
Clinical Trials Status at Dicle Uni Medical Faculty; Internal Medicine
Currently, there are NaN active trials in "Dicle Uni Medical Faculty; Internal Medicine".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Dicle Uni Medical Faculty; Internal Medicine,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Dicle Uni Medical Faculty; Internal Medicine, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".